Study details
Enrolling now
A Study of BIO 300 and Thoracic Radiation Therapy
Memorial Sloan Kettering Cancer Center
NCT IDNCT07323732ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
25
Study length
about 3 years
Ages
18+
Locations
7 sites in NJ, NY
What this study is about
This trial is testing whether giving BIO 300 along with radiation therapy can help prevent lung inflammation (pneumonitis) in people with non-small cell lung cancer and interstitial lung disease. The study will last for about a year.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take BIO 300
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Oncology, Respiratory